)
Visual
test
Advanced Enzyme Technologies
Advanced Enzyme Technologies (ADVENZYMES) investor relations material
Advanced Enzyme Technologies Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary4 Feb, 2026
Executive summary
Q3 FY26 revenue was INR 1,719 million, up 2% year-over-year but down 7% sequentially; nine-month revenue grew 15% year-over-year to INR 5,424 million.
Q3 EBITDA declined 11% year-over-year to INR 494 million, while PAT increased 11% to INR 432 million; nine-month PAT rose 20% to INR 1,284 million.
Human Healthcare contributed 56% of Q3 revenue, with Animal Healthcare and Bioprocessing showing strong growth.
Board approved up to 26% equity investment in a Group Captive Wind Power Plant SPV and discontinued plans for a solar project.
Approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.
Financial highlights
Q3 revenue: INR 1,719 million (+2% YoY, -7% QoQ); nine-month revenue: INR 5,424 million (+15% YoY).
Q3 EBITDA: INR 494 million (-11% YoY, -18% QoQ); nine-month EBITDA: INR 1,658 million (+11% YoY).
Q3 PAT: INR 432 million (+11% YoY, -3% QoQ); nine-month PAT: INR 1,284 million (+20% YoY).
Consolidated net profit for Q3 FY26: Rs 582.91 million, compared to Rs 530.21 million YoY.
EPS for Q3 FY26 was ₹3.80, up 13% year-over-year.
Outlook and guidance
Management expects double-digit growth (13–15%) over the next 3–5 years, with continued focus on healthcare and expansion into new enzyme applications.
Focus areas include expanding animal nutrition, probiotics, bio-catalysis, and baking solutions, with new product launches and global distribution.
Continued investment in R&D, inorganic expansion, and strategic partnerships are highlighted as growth drivers.
U.S. market outlook is improving with more inquiries and interest, though tariffs and market uncertainty remain challenges.
New R&D center in Nashik to focus on strain development, protein engineering, and fermentation, expected to accelerate innovation.
Wind power SPV: expected energy cost savings?
Lawsuit reversal: impact on future legal risks?
Advanced Nutrazyme: target market and products?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- AAK
Profitability improved despite lower volumes; higher dividends and share buyback proposed. - MILDEF
Record growth and profitability in Q4 and 2025, driven by RODA and strong order intake. - 500570
JLR's cyber incident drove a 25.8% revenue drop, but domestic PV business surged 24% YoY. - DOO
Q3 revenue and net income surged, prompting higher FY26 guidance amid industry headwinds. - METS
Profitability turned negative despite higher sales, with cost savings and restructuring underway. - KCR
Record profitability and strong orders in 2025, with net profit up 8.5% year-over-year. - 532548
Q3 revenue up 18.4% YoY, margin gains, and expansion plans drive strong outlook despite risks. - GALE
Strong sales and profit growth, digital expansion, and higher dividend proposed for 2024. - BPE
Adjusted net profit hit €2.1bn, with a 75% payout and BPSO integration progressing. - MANE
VDPHL01 could reshape PHL treatment with rapid, consistent results and broad market potential.
Next Advanced Enzyme Technologies earnings date
Q4 25/2615 May, 2026
Advanced Enzyme Technologies
Next Advanced Enzyme Technologies earnings date
Q4 25/2615 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Advanced Enzyme Technologies Limited is an India-based biotechnology company that manufactures and markets enzymes and probiotics. The company supplies products for industries including pharmaceuticals, food and beverage, animal nutrition, and textiles. It operates manufacturing and research facilities across India and internationally. Advanced Enzyme Technologies Limited is headquartered in Thane, India, and its shares are listed on the NSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage